The ODPRN is not currently conducting drug class reviews at this time.
The ODPRN has completed a total of 12 drug class reviews since 2013. These reviews were based on an innovative framework that incorporated systematic reviews and network meta-analysis, economic modeling, real-world prescribing and adherence, qualitative analysis of patient and clinician perspectives, and an environmental scan of listing across Canada. Research findings were synthesized to make recommendations to the Ontario Ministry of Health and Long-Term Care regarding public drug reimbursement policies.
All completed reviews contain the following:
- The final research plan: A detailed description of how each study was conducted within the drug class review;
- All final research reports: Includes a consolidated report of all research findings and proposed reimbursement options; and
- Resources: Summaries and infographics to facilitate understanding of our drug class review findings.
List of completed reviews
|Low Molecular Weight Heparin||August 2015||May 2016|
|Treatment for Overactive Bladder||April 2015||March 2016|
|Drugs for the Management of Attention-Deficit/Hyperactivity Disorder||March 2015||December 2015|
|Allergen Immunotherapy||May 2015||October 2015|
|Treatments for Chronic Hepatitis B||September 2014||September 2015|
|Cognitive Enhancers for Alzheimer's Disease||November 2014||August 2015|
|Triptans for the Management of Acute Episodic Migraine||August 2013||March 2014|
|Testosterone Replacement Therapy||April 2014||December 2014|
|Respiratory Reviews||November 2013||April 2015|
|Antipsychotics in the Elderly||August 2014||May 2015|